Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab.
Bartke
U
U
Venten
I
I
Kreuter
A
A
Gubbay
S
S
Altmeyer
P
P
Brockmeyer
N H
NH
Gabbay
S
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000150:complications*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D003879:Dermatologic Agents; D000069285:Infliximab